Lidamidine (BioDeep_00000180470)

   

human metabolite blood metabolite


代谢物信息卡片


N-(2,6-dimethylphenyl)-N-(N-methylcarbamimidoyl)carbamimidic acid

化学式: C11H16N4O (220.13240459999997)
中文名称: 利达脒
谱图信息: 最多检出来源 Homo sapiens(blood) 80%

分子结构信息

SMILES: CC1=C(C(=CC=C1)C)NC(=O)NC(=NC)N
InChI: InChI=1S/C11H16N4O/c1-7-5-4-6-8(2)9(7)14-11(16)15-10(12)13-3/h4-6H,1-3H3,(H4,12,13,14,15,16)

描述信息

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent
D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals

同义名列表

8 个代谢物同义名

N-(2,6-dimethylphenyl)-N-(N-methylcarbamimidoyl)carbamimidic acid; N-(2,6-dimethylphenyl)-N-(N-methylcarbamimidoyl)carbamimidate; 1-(2,6-dimethylphenyl)-3-(N-methylcarbamimidoyl)urea; 1-(2,6-Dimethylphenyl)-3-methylamidinourea; Lidamidine, monohydrochloride; Lidamidine, hydrochloride; Lidamidine; WHR-1142a



数据库引用编号

5 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Daniel J Warner, Hongming Chen, Louis-David Cantin, J Gerry Kenna, Simone Stahl, Clare L Walker, Tobias Noeske. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals. 2012 Dec; 40(12):2332-41. doi: 10.1124/dmd.112.047068. [PMID: 22961681]
  • E Y Eaker, G B Bixler, J R Mathias. WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats. The Journal of pharmacology and experimental therapeutics. 1988 Aug; 246(2):786-9. doi: NULL. [PMID: 3404458]
  • J F DiJoseph, G N Mir. Hyperglycemic effect of lidamidine in the rat. Archives internationales de pharmacodynamie et de therapie. 1987 Aug; 288(2):300-8. doi: NULL. [PMID: 2890331]
  • C A Edwards, N W Read. Effect of lidamidine, a proposed alpha 2-adrenoreceptor agonist, on salt and water transport in human jejunum. Digestive diseases and sciences. 1986 Aug; 31(8):817-21. doi: 10.1007/bf01296049. [PMID: 2873974]
  • C Edwards, P A Cann, N W Read, C D Holdsworth. Effect of two new antisecretory drugs on fluid and electrolyte transport in a patient with secretory diarrhoea. Gut. 1986 May; 27(5):581-6. doi: 10.1136/gut.27.5.581. [PMID: 2870957]
  • J A Allen, E Jones, J C Richardson, M Richold. Absence of mutagenic activity of WHR-1142A, lidamidine hydrochloride, in 4 short-term tests for mutagenic/carcinogenic potential. Mutation research. 1983 Mar; 116(3-4):399-405. doi: 10.1016/0165-1218(83)90078-2. [PMID: 6339900]
  • J G Heredia Díaz, I Alcántara, A Solís. [Evaluation of the safety and effectiveness of WHR-1142A in the treatment of non-specific acute diarrhea]. Revista de gastroenterologia de Mexico. 1979 Oct; 44(4):167-73. doi: NULL. [PMID: 394268]
  • G N Mir, R L Alioto, J W Sperow, J R Eash, J B Krebs, J Yelnosky. In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide. Arzneimittel-Forschung. 1978; 28(8a):1448-54. doi: . [PMID: 582536]